Indication
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1 clinical trial
2 products
Product
VGX-3100Clinical trial
A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the VulvaStatus: Completed, Estimated PCD: 2020-07-23
Product
Imiquimod